Breaking El Al's monopoly on key air route, smaller Israeli company Israir to start direct New York City-Tel Aviv route
Department of Transportation approval allows Israir to challenge El Al’s dominance of major route
Israel's budget airline company, Israir Airlines announced on Monday that it had received official approval from the United States Department of Transportation (DOT) to operate flights to the United States on the high-demand Tel Aviv - New York route.
The initial approval, which is expected to be finalized in June, according to a timeline shown to the board of directors, will be a temporary license for two years.
The DOT approval allows Israir to begin working on achieving compliance with Federal Aviation Administration and Transportation Security Administration regulations. If the airline demonstrates compliance with the standards during that time, it will be granted a permanent license.
According to Globes, Israir will begin by operating Airbus A330 aircraft on a dry lease, using the company’s own employees. The company reportedly plans to begin flights around Passover 2026, but it has not yet indicated how many flights per week it intends to offer.
Israir previously offered flights to the United States, but discontinued them several years ago after finding the routes economically unfeasible. However, after the start of the war, U.S. airlines canceled their flights, leaving El Al the only company flying the routes.
The approval represents a significant step in Israir’s efforts to expand its air routes and compete with other Israeli airlines, particularly El Al.
Throughout the Gaza War, El Al has been the only company offering regular service to and from the U.S., allowing the company to gain a near monopoly on the main air routes between the two countries.
Even as some U.S. airlines have begun resuming flights, some Israelis have continued to choose El Al, seeing it as a secure choice, which also benefits Israel.
While Arkia, another budget Israeli airline, has also begun flying the Tel Aviv - New York route in February, El Al’s practical monopoly has not really been challenged.
Arkia currently operates 3 weekly flights to the U.S. compared to El Al’s 52 weekly flights. Some U.S. airlines, such as Delta, have resumed flights to and from Israel, while others, such as American Airlines, have yet to announce a resumption of flights. Some foreign airlines offer flights to the U.S., but do so via connections in other countries.
This has allowed El Al to continue to dominate the U.S.-Israel market and maintain high prices on its tickets. Now, El Al’s dominance could be challenged by another Israeli airline offering direct flights.
While the Passover holiday season represents one of the busiest seasons for travel to Israel, the Flight Hunter website said earlier today that the number of travelers through the Ben Gurion International Airport remains high following the official end of the Passover holiday.
According to the site, approximately 77,000 passengers are expected to pass through the airport on 479 international flights today.
Popular article:
interview Easter message of resurrection hope amid war at Jerusalem's Garden Tomb
biblical commentary Let my people go: a Passover message for today
4 IDF soldiers killed, 2 wounded in fighting in southern Lebanon, as Israel eliminates dozens of Hezbollah terrorists
Receive latest news & updates
A message from All Israel News
Help us educate Christians on a daily basis about what is happening in Israel & the Middle East and why it matters.
For as little as $10, you can support ALL ISRAEL NEWS, a non-profit media organization that is supported by readers like you.
Latest articles:
1969 Dutch Eurovision winner Lenny Kuhr moves to Israel – cites antisemitism, family ties
Israel bars French far-left leader Mélenchon in response to France's entry ban on settlement leader
Change Bloc divided over coalition with Arab or ultra-Orthodox parties after week of negotiations
Huckabee fires back as Senate Democrats target US-Israel intelligence ties: 'Shocking!'
Israeli blood test detects early breast cancer with 95% accuracy, assesses recurrence risk